In the case of Marico Limited vs Minolta Natural Care, the court examined whether the defendants’ Jasmine and Hair Protection hair oil products unlawfully copied the distinctive trade dress, logos, and packaging of the plaintiff’s well known Jasmine and Hair and Care hair oil products sold under the Parachute house mark, and granted interim relief to the plaintiff.
Read more about Same Hair, Same Care, Same Jasmine: Too Familiar for Trade Mark and Copyright ComfortTag: interim injunction
“Little Hearts”, Big Infringement: Delhi HC Injunction
An ad interim injunction was granted by the Delhi High Court in a dispute concerning the “Little Hearts” mark, 3D biscuit shape, trade dress and product images. Amazon was directed to delist the infringing listings pending further orders.
Read more about “Little Hearts”, Big Infringement: Delhi HC InjunctionUNPLUG YOURSELF Allowed, BOULT Logos Still Blocked
In the case of Exotic Mile vs Imagine Marketing Pvt Ltd, the court considered claims of trademark infringement and passing off in relation to competing marks used for audio devices. It limited interim relief to the scope of the pleadings and clarified the legal position on unpleaded claims.
Read more about UNPLUG YOURSELF Allowed, BOULT Logos Still BlockedDr Reddy’s Semaglutide Exports to Continue as Court Denies Interim Relief to Novo Nordisk
The Delhi High Court refused Novo Nordisk interim relief against Dr Reddy’s, finding that the Semaglutide species patent faces serious validity challenges in light of the earlier genus patent. The Court allowed Dr Reddy’s to continue manufacturing Semaglutide in India solely for export to non-patent jurisdictions, with no domestic sales.
Read more about Dr Reddy’s Semaglutide Exports to Continue as Court Denies Interim Relief to Novo NordiskFrimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement Case
In Frimline v. K-SMATCO, Delhi HC granted interim relief over patent IN 382949, citing strong prima facie infringement of Frimline’s pharmaceutical formulation.
Read more about Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement CaseInjunction in V3 Trademark Dispute Denied Over Unclean Hands
The Bombay High Court refused interim relief in the V3 trademark dispute, finding both parties had suppressed facts and acted inconsistently. The decision underscores that equitable remedies require parties to come with clean hands.
Read more about Injunction in V3 Trademark Dispute Denied Over Unclean HandsProducts Made During Patent Term are Infringing Even After Expiry
In the case of Boehringer Ingelheim v. Femilab Healthcare, the Himachal Pradesh High Court ruled that interim injunctions granted to prevent patent infringement cannot continue after the patent has expired. The court held that such relief loses effect with the end of the patent term. However, it stated that infringing products made during the patent’s validity may still be restrained from being sold or used after the patent expires.
Read more about Products Made During Patent Term are Infringing Even After ExpiryDelhi High Court Patent Injunction: Aquestia Wins Against Automat Industries
Delhi High Court grants patent injunction to Aquestia, stopping Automat from selling Hydromat valves over suspected patent infringement.
Read more about Delhi High Court Patent Injunction: Aquestia Wins Against Automat IndustriesPatented But Still Infringing: Delhi HC Stops Hydromat Valve Sales
In the case of Aquestia Limited vs Automat Industries Private Limited & Ors., the Delhi High Court granted an interim injunction restraining the defendants from manufacturing and selling their ‘Hydromat’ valves. The court held that even a patented product can infringe an earlier patent, and found that the defendants’ valves incorporated the core features of the plaintiff’s fluid control valve patent claims.
Read more about Patented But Still Infringing: Delhi HC Stops Hydromat Valve SalesSquibb Secures Interim Injunction Against Zydus in Nivolumab Patent Dispute
The Delhi High Court has issued an interim injunction restraining Zydus from launching its Nivolumab biosimilar, siding with Squibb’s claim of imminent patent infringement.
Read more about Squibb Secures Interim Injunction Against Zydus in Nivolumab Patent Dispute